---
title: "KRAMER HILARY — Ownership Dossier"
canonical: https://whiteintel.dev/entity/0b2567b7-35cd-5312-ae6c-c01ac64d37d2
json: https://whiteintel.dev/api/public/dossier/0b2567b7-35cd-5312-ae6c-c01ac64d37d2
identifier: sec:0002071192
jurisdiction: US
risk: Low
source: WhiteIntel corporate-ownership graph
---

# KRAMER HILARY

**Type:** Company  
**Jurisdiction:** [US](https://whiteintel.dev/jurisdictions/us)  
**Identifier:** `sec:0002071192`  
**Risk level:** Low  
**Canonical dossier:** https://whiteintel.dev/entity/0b2567b7-35cd-5312-ae6c-c01ac64d37d2  
**Structured JSON / MCP:** https://whiteintel.dev/api/public/dossier/0b2567b7-35cd-5312-ae6c-c01ac64d37d2  

## Ownership & control

### Holdings / subsidiaries

- **GT BIOPHARMA, INC.** (director) — https://whiteintel.dev/entity/d3759628-f2cc-5dde-b59e-0381451f537e

---

_This is the markdown-for-agents view of the WhiteIntel dossier for **KRAMER HILARY**. Human view: https://whiteintel.dev/entity/0b2567b7-35cd-5312-ae6c-c01ac64d37d2 · Structured JSON: https://whiteintel.dev/api/public/dossier/0b2567b7-35cd-5312-ae6c-c01ac64d37d2._

_Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership. Every claim carries a source; an absent edge means "not yet observed in current sources", not "does not exist"._